GLP-1 Diabetes Drug Mounjaro Gets FDA Okay to Reduce Heart Attack and Stroke
Mounjaro Beat Trulicity in Trial Results The FDA approval was based on results looking at cardiovascular outcomes with Mounjaro and Trulicity (dulaglutide), in a trial involving more than 13,000 adults…